brand logo

Am Fam Physician. 2024;109(5):online

Are patients with nonerosive gastroesophageal reflux disease at an increased risk of esophageal cancer compared with the average population?

A prospective cohort study followed more than 480,000 patients in Scandinavia for 32 years after undergoing endoscopy and found that nonerosive gastroesophageal reflux disease does not increase the likelihood of esophageal cancer. However, erosive gastroesophageal reflux disease is associated with a doubled, but still low, risk of developing cancer, with the likelihood increasing over time.

What should be included when counseling individuals who desire a levonorgestrel intrauterine device?

Approximately 35% of patients with a levonorgestrel intrauterine device will experience frequent or prolonged bleeding in the first 3 months after insertion, but systematic reviews have shown that most patients will experience a reduction in bleeding within 12 months of use.

Already a member/subscriber?  Log In


From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available

Issue Access

  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Continue Reading

More in AFP

More in PubMed

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.